Alkeon Capital Management LLC Agios Pharmaceuticals, Inc. Transaction History

Alkeon Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$33.87 - $55.93 $16.7 Million - $27.5 Million	-491,615 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$30.08 - $50.59 $8.87 Million - $14.9 Million	-295,000 Reduced 37.5%	491,615 $23.5 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $3.24 Million - $4.96 Million	100,000 Added 14.56%	786,615 $25.5 Million
Q1 2019 May 15, 2019	BUY	$45.92 - $67.67 $10.9 Million - $16.1 Million	237,500 Added 52.88%	686,615 $46.3 Million
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $10.5 Million - $18.7 Million	-244,839 Reduced 35.28%	449,115 $20.7 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $11,825 - $15,171	165 Added 0.02%	693,954 $53.5 Million
Q2 2018 Aug 14, 2018	BUY	$73.22 - $99.55 $1.83 Million - $2.49 Million	25,000 Added 3.74%	693,789 $58.4 Million
Q1 2018 May 15, 2018	BUY	$59.83 - $86.53 $9.4 Million - $13.6 Million	157,170 Added 30.72%	668,789 $54.7 Million
Q4 2017 Feb 15, 2018	BUY	$52.12 - $72.33 $2.86 Million - $3.97 Million	54,858 Added 12.01%	511,619 $29.3 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $25.1 Million - $30.7 Million	456,761	456,761 $30.5 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Alkeon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alkeon Capital Management LLC with notifications on news.